Repurposing of Kinase Inhibitors for Treatment of COVID-19.
Weisberg E, Parent A, Yang PL, Sattler M, Liu Q, Liu Q, Wang J, Meng C, Buhrlage SJ, Gray N, Griffin JD.
Weisberg E, et al. Among authors: sattler m.
Pharm Res. 2020 Aug 10;37(9):167. doi: 10.1007/s11095-020-02851-7.
Pharm Res. 2020.
PMID: 32778962
Free PMC article.
Review.